Kenneth B. Hymes

3.7k total citations · 1 hit paper
44 papers, 2.6k citations indexed

About

Kenneth B. Hymes is a scholar working on Pathology and Forensic Medicine, Dermatology and Oncology. According to data from OpenAlex, Kenneth B. Hymes has authored 44 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 21 papers in Dermatology and 13 papers in Oncology. Recurrent topics in Kenneth B. Hymes's work include Cutaneous lymphoproliferative disorders research (21 papers), Lymphoma Diagnosis and Treatment (21 papers) and T-cell and Retrovirus Studies (9 papers). Kenneth B. Hymes is often cited by papers focused on Cutaneous lymphoproliferative disorders research (21 papers), Lymphoma Diagnosis and Treatment (21 papers) and T-cell and Retrovirus Studies (9 papers). Kenneth B. Hymes collaborates with scholars based in United States, Denmark and Germany. Kenneth B. Hymes's co-authors include Alvin E. Friedman‐Kien, Franco M. Muggia, L Laubenstein, Simon Karpatkin, Miranda Ritterman Weintraub, Madeleine Duvic, Michael Marmor, Rita I. Demopoulos, Patricia L. Myskowski and Len Farol and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Kenneth B. Hymes

44 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kaposis sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California.

1981 696 citations Alvin E. Friedman‐Kien, L Laubenstein et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers

Countries citing papers authored by Kenneth B. Hymes

Since Specialization

Citations

This map shows the geographic impact of Kenneth B. Hymes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth B. Hymes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth B. Hymes more than expected).

Fields of papers citing papers by Kenneth B. Hymes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth B. Hymes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth B. Hymes. The network helps show where Kenneth B. Hymes may publish in the future.

Co-authorship network of co-authors of Kenneth B. Hymes

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth B. Hymes. A scholar is included among the top collaborators of Kenneth B. Hymes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth B. Hymes. Kenneth B. Hymes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures 2021 ·Blood ·Alberto Herrera, Anthony Cheng, Eleni P. Mimitou, (unknown), (unknown), Michal Bar‐Natan, Adriana Heguy, Kelly V. Ruggles, José U. Scher, Kenneth B. Hymes, Jo‐Ann Latkowski, Niels Ødum, Marshall E. Kadin, Zhengqing Ouyang, Larisa J. Geskin, Peter Smibert, Terkild B. Buus, Sergei B. Koralov	45
2	Esophageal cancer as initial presentation of Fanconi anemia in patients with a hypomorphic FANCA variant 2020 ·Molecular Case Studies ·Francis P. Lach, Sonia Singh, Kimberly A. Rickman, Penelope D. Ruiz, (unknown), Kenneth B. Hymes, Mark D. DeLacure, Jennifer A. Kennedy, Settara C. Chandrasekharappa, Agata Smogorzewska	11
3	Management of Intraoperative Coagulopathy 2018 ·Neurosurgery Clinics of North America ·Michal Bar‐Natan, Kenneth B. Hymes	5
4	149 Analysis of molecular etiology and bacterial triggers of cutaneous T cell lymphoma 2017 ·Journal of Investigative Dermatology ·(unknown), Amy Sun, Laura K. Fogli, (unknown), William E. Sause, Kasthuri Kannan, Igor Dolgalev, Adriana Heguy, Yi Fulmer, Mark S. Sundrud, Jeffrey L. Kutok, Niels Ødum, Swati Goel, Jo‐Ann Latkowski, Victor J. Torres, Kenneth B. Hymes, Bo Shopsin, Sergei B. Koralov	1
5	A Phase II trial of Belinostat ( PXD 101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma 2014 ·British Journal of Haematology ·Francine M. Foss, Ranjana H. Advani, Madeleine Duvic, Kenneth B. Hymes, Tanin Intragumtornchai, Arnuparp Lekhakula, Ofer Shpilberg, Adam Lerner, Robert J. Belt, Eric D. Jacobsen, Guy Laurent, Dina Ben‐Yehuda, M. Beylot‐Barry, Uwe Hillen, Poul Knoblauch, Gajanan Bhat, Shanta Chawla, Lee F. Allen, Brad Pohlman	161
6	Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma 2013 ·Annals of Oncology ·David J. Straus, Madeleine Duvic, Sarah McCue Horwitz, Kenneth B. Hymes, André Goy, Francisco J. Hernandez‐Ilizaliturri, Tatyana Feldman, (unknown), Patricia L. Myskowski	23
7	Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma:in vitroand phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition 2012 ·Leukemia & lymphoma ·Reinhard Dummer, Marc Beyer, Kenneth B. Hymes, Mirjam T. Epping, René Bernards, Matthias Steinhoff, Wolfram Sterry, Helmut Kerl, Karl Heath, (unknown), James S. Hardwick, J. Garcia‐Vargas, Katrin Baumann, Syed Rizvi, Stanley R. Frankel, Sean Whittaker, Chalid Assaf	51
8	If Vitamins Could Kill: Massive Hemolysis Following Naturopathic Vitamin Infusion 2011 ·Journal of Medical Toxicology ·Zhanna Livshits, Robert S. Hoffman, Kenneth B. Hymes, Lewis S. Nelson	1
9	The Role of Histone Deacetylase Inhibitors in the Treatment of Patients With Cutaneous T-Cell Lymphoma 2010 ·Clinical Lymphoma Myeloma & Leukemia ·Kenneth B. Hymes	24
10	A 61-Year-Old-Man With Massive Intravascular Hemolysis 2009 ·CHEST Journal ·Amit Uppal, Kenneth B. Hymes, David R. Schwartz	10
11	Vorinostat in combination with bexarotene in advanced cutaneous T-cell lymphoma: A phase I study 2009 ·Journal of Clinical Oncology ·Reinhard Dummer, Kenneth B. Hymes, Wolfram Sterry, (unknown), Chalid Assaf, H. Kerl, (unknown), Syed Rizvi, Justin L. Ricker, Sean Whittaker	15
12	CD20 positive mycosis fungoides: a case report 2008 ·Journal of Cutaneous Pathology ·Filiz Şen, Steven S. Kang, Joan Cangiarella, Hideko Kamino, Kenneth B. Hymes	24
13	Bexarotene: a clinical review 2004 ·Expert Review of Anticancer Therapy ·Len Farol, Kenneth B. Hymes	109
14	Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results 2001 ·Journal of Clinical Oncology ·Madeleine Duvic, Kenneth B. Hymes, Peter Heald, Debra Breneman, Ann Martin, Patricia L. Myskowski, (unknown), Richard C. Yocum, (unknown)	479
15	Mycosis Fungoides Metastasizing to the Brain Parenchyma: Case Report 1998 ·Neurosurgery ·Martin Zonenshayn, Suash Sharma, Kenneth B. Hymes, Edmond A. Knopp, John G. Golfinos, David Zagzag	17
16	Human immunodeficiency virus infection and thrombotic microangiopathy. 1997 ·PubMed ·Kenneth B. Hymes, Simon Karpatkin	54
17	Large‐cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome 1996 ·British Journal of Haematology ·(unknown), Giorgio Inghirami, Yuichi Masuda, F Vandekerckhove, Bruce G. Raphael, Edward L. Amorosi, Kenneth B. Hymes, Glauco Frizzera	67
18	Improved long term survival after intracavitary interleukin-2 and lymphokine-activated killer cells for adults with recurrent malignant glioma 1995 ·Cancer ·Roberta L. Hayes, Maxim Koslow, Emile Hiesiger, Kenneth B. Hymes, (unknown), (unknown), Howard S. Höchster, (unknown), Gleb N. Budzilovich, Joseph Ransohoff	145
19	Kaposis sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. breakdown → 1981 ·MMWR Morbidity and Mortality Weekly Report ·Alvin E. Friedman‐Kien, L Laubenstein, Michael Marmor, Kenneth B. Hymes, (unknown), (unknown), (unknown), Franco M. Muggia, Rita I. Demopoulos, Miranda Ritterman Weintraub	696
20	Heavy-chain subclass of round antiplatelet IgG in autoimmune thrombocytopenic purpura 1980 ·Blood ·Kenneth B. Hymes, P H Schur, Simon Karpatkin	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact